Quality Use of Generic Medicines
暂无分享,去创建一个
[1] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[2] D. Ames,et al. Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit , 2002, International journal of geriatric psychiatry.
[3] A. Kjaer,et al. Serotonin Receptors Involved in Vasopressin and Oxytocin Secretion , 2003, Journal of neuroendocrinology.
[4] N. Chapman,et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials , 2000, The Lancet.
[5] S. Myers. Interactions between complementary medicines and warfarin , 2002 .
[6] A. Laupacis,et al. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. , 1999, Archives of internal medicine.
[7] S. West,et al. Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study , 2002 .
[8] P. Phillips. Insulins in 2002 , 2002 .
[9] A. Gallus,et al. Managing warfarin therapy in the community , 2001 .
[10] C. Reid,et al. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. , 2003, The New England journal of medicine.
[11] S. Faraone,et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. , 1998, The American journal of psychiatry.
[12] L. Ryysy,et al. Comparison of Bedtime Insulin Regimens in Patients with Type 2 Diabetes Mellitus , 1999, Annals of Internal Medicine.
[13] M. Gent,et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.
[14] K. Parhofer,et al. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia. , 2001, The American journal of cardiology.
[15] P. Froom,et al. Oral anticoagulants in the elderly , 2003, British journal of haematology.
[16] D. Sherman,et al. The secondary prevention of stroke in patients with atrial fibrillation. , 1986, Archives of neurology.
[17] Donald J. Birkett,et al. Generics - equal or not? , 2003 .
[18] T. Dunning. Insulin delivery devices , 2002 .
[19] P. Wolf,et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke , 1978, Neurology.
[20] J. Vandenbroucke,et al. Assessment of a Bleeding Risk Index in Two Cohorts of Patients Treated with Oral Anticoagulants , 1996, Thrombosis and Haemostasis.
[21] D. Singer,et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. , 1996, The New England journal of medicine.
[22] J. Wernicke,et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. , 2001, Pediatrics.
[23] O. Spigset,et al. Hyponatremia in Relation to Treatment with Antidepressants: A Survey of Reports in the World Health Organization Data Base for Spontaneous Reporting of Adverse Drug Reactions , 1997, Pharmacotherapy.
[24] Panos Kanavos,et al. Encouraging the use of generic medicines: implications for transition economies. , 2002, Croatian medical journal.
[25] G. McColl,et al. Experimental and clinical pharmacology : Tumour necrosis factor alpha inhibitors for the treatment of adult rheumatoid arthritis , 2004 .
[26] K. Pile,et al. Disease modifying drugs in adult rheumatoid arthritis , 2003 .
[27] M. Hochberg,et al. Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis , 2003, Annals of the rheumatic diseases.
[28] S. West,et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies , 2003, Biological Psychiatry.
[29] A. Laupacis,et al. Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation. , 2002, Archives of internal medicine.
[30] L Goldman,et al. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. , 1989, The American journal of medicine.
[31] D. Reda,et al. Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. , 2000, Archives of internal medicine.
[32] L. Joosten,et al. Long term anti-tumour necrosis factor α monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation , 2002, Annals of the rheumatic diseases.
[33] J. Peláez de Loño. [Generic medicines]. , 1999, Revista de enfermeria.
[34] G. Raskob,et al. Hemorrhagic complications of anticoagulant treatment. , 1992, Chest.
[35] J. Hirsh,et al. Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. , 2000, Archives of internal medicine.
[36] J. Biederman,et al. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.
[37] Yuchiao Chang,et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.
[38] J. Després,et al. Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL‐cholesterol levels: a 12‐week randomized trial , 2002, Journal of internal medicine.
[39] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.
[40] M. Weisman,et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. , 2003, Arthritis and rheumatism.
[41] P. Ridker,et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.
[42] L. Vanhaelst,et al. Comparison of Micronized Fenofibrate and Pravastatin in Patients With Primary Hyperlipidemia , 2003, Journal of cardiovascular pharmacology.
[43] K. Kaye. Trouble with tramadol , 2004 .
[44] W. Gulliver,et al. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. , 2002, Journal of the American Academy of Dermatology.